Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -32.80%-1.19M | -87.84%47.18K | 153.37%197.76K | 84.15%-503.33K | 147.88%374.68K | 28.87%-895.45K | 150.67%388.02K | -0.36%-370.57K | 11.94%-3.18M | -46.73%-782.54K |
| Net income from continuing operations | -90.10%1.06M | 123.55%410.81K | 37.78%-522.02K | 103.13%544.91K | 39.56%-7.53M | 513.76%10.66M | -39.14%-1.74M | 23.47%-838.97K | 39.17%-17.39M | 15.77%-12.46M |
| Operating gains losses | 99.62%-28.12K | -337.89%-1.12M | 554.66%366.31K | -1,332.88%-8.43M | -21.43%-1.39M | -2,068.11%-7.43M | 132.32%469.31K | -247.56%-80.57K | -208.60%-588.49K | -407.88%-1.14M |
| Depreciation and amortization | 115.86%129.61K | -75.82%120.08K | 91.51%113.95K | -75.56%692.03K | -90.42%75.8K | -90.88%60.04K | -24.31%496.68K | -91.81%59.5K | -3.05%2.83M | -17.37%791.08K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 17.04%1.95M | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | -54.81%360.39K | --360.39K | ---- | ---- | ---- | 41.15%797.55K | ---- |
| Unrealized gains and losses of investment securities | 69.22%-1.1M | ---- | ---- | 33.01%5.29M | 51.25%8.43M | -1,493.53%-3.57M | ---- | ---- | -66.53%3.97M | -7.26%5.57M |
| Remuneration paid in stock | -56.40%39.47K | 35.50%298.3K | -81.16%41.51K | -49.22%822.89K | -76.39%291.88K | -58.35%90.53K | 45.42%220.16K | 1,337.27%220.32K | 55.22%1.62M | 103.92%1.24M |
| Deferred tax | ---- | ---- | ---- | 65.56%-122.78K | 55.04%-122.78K | --0 | --0 | --0 | -10.02%-356.56K | -13.49%-273.12K |
| Other non cashItems | 153.25%119.08K | -70.54%117.73K | -92.51%11.15K | -87.86%268.35K | -103.95%-56.63K | -188.96%-223.61K | 46.00%399.65K | -40.79%148.94K | -54.89%2.21M | -60.72%1.43M |
| Change In working capital | -168.43%-1.31M | -45.67%67.5K | 55.45%186.86K | -95.70%76.34K | -75.85%318.14K | -848.49%-486.25K | -79.57%124.24K | 155.78%120.21K | -0.90%1.78M | 94.92%1.32M |
| -Change in receivables | -58.27%-154.04K | -118.16%-148.12K | -30.35%24.98K | 100.08%57 | 30.58%129.42K | -262.46%-97.32K | 34.85%-67.89K | 182.96%35.86K | -138.18%-75.17K | -43.47%99.11K |
| -Change in inventory | --0 | --0 | --0 | 844.59%4.89K | 89.64%-5.72K | -73.27%11.36K | -107.89%-1.05K | --304 | 100.12%518 | -175.25%-55.22K |
| -Change in prepaid assets | -333.07%-867.86K | 2,004.43%91.14K | -387.96%-128.81K | -141.51%-123.67K | -86.75%27.67K | -102.07%-200.4K | -98.59%4.33K | 137.81%44.73K | 24,583.24%297.96K | -49.91%208.82K |
| -Change in payables and accrued expense | -92.46%-442.47K | -98.40%4.75K | -125.37%-61.17K | -84.22%236.3K | -106.20%-71.21K | -287.88%-229.9K | 4,751.22%296.33K | 3.54%241.08K | 120.66%1.5M | 567.80%1.15M |
| -Change in other working capital | 430.12%159.12K | 211.39%119.73K | 274.39%351.86K | -176.12%-41.24K | 383.17%237.99K | 14.83%30.02K | -126.95%-107.48K | 29.65%-201.77K | -95.94%54.18K | -132.85%-84.04K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -32.80%-1.19M | -87.84%47.18K | 153.37%197.76K | 84.15%-503.33K | 147.88%374.68K | 28.87%-895.45K | 150.67%388.02K | -0.36%-370.57K | 11.94%-3.18M | -46.73%-782.54K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -136.88%-330.11K | 25.11%-354.84K | -26.64%-175.58K | -114.44%-213.04K | 22.78%-495.7K | -58.92%895.1K | -1,494.57%-473.79K | -338.27%-138.65K | 282.55%1.48M | -196.77%-641.95K |
| Net PPE purchase and sale | --0 | ---774 | ---1.22K | --0 | --0 | --0 | --0 | --0 | -101.63%-3.23K | -105.10%-375 |
| Net intangibles purchas and sale | 54.68%-379.56K | ---380.8K | ---334.02K | -466.73%-1.18M | -65.31%-344.91K | ---837.52K | --0 | --0 | 63.03%-208.64K | 6.35%-208.64K |
| Net business purchase and sale | --0 | --0 | --0 | -2,148.77%-302.01K | 5.85%-295.1K | --446.17K | ---270.19K | ---182.89K | 93.29%-13.43K | ---313.43K |
| Net investment purchase and sale | -92.44%48.49K | --26.74K | --18.24K | 81.37%657.46K | -94.77%15.68K | --641.78K | --0 | --0 | 237.94%362.5K | 60,100.00%300K |
| Net other investing changes | -99.85%963 | --0 | 219.63%141.42K | -54.13%613.95K | 130.66%128.63K | -65.74%644.67K | -120.79%-203.6K | 239.85%44.24K | 483.00%1.34M | -112,369.17%-419.51K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -136.88%-330.11K | 25.11%-354.84K | -26.64%-175.58K | -114.44%-213.04K | 22.78%-495.7K | -58.92%895.1K | -1,494.57%-473.79K | -338.27%-138.65K | 282.55%1.48M | -196.77%-641.95K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,963.89%14.76M | -40.47%121.57K | 15,536.53%4.81M | -289.95%-181.11K | -92.56%27.71K | -226.43%-381.9K | 562.32%204.23K | 73.18%-31.15K | -97.53%95.35K | -81.40%372.69K |
| Net issuance payments of debt | 23,935.67%10.62M | --0 | --0 | -215.84%-192.67K | -129.00%-72.51K | ---44.57K | -378.99%-44.44K | 58.13%-31.15K | -91.80%166.32K | 236.76%250K |
| Net common stock issuance | --0 | --0 | --4.8M | ---- | ---- | --0 | --0 | --0 | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --3.58M | --78.67K | --80.16K | --33K | --33K | --0 | --0 | --0 | --0 | ---- |
| Interest paid (cash flow from financing activities) | ---60K | ---20K | ---60K | ---80K | ---80K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | 280.96%610.43K | -69.20%62.9K | -190.44%-8K | 182.50%58.55K | 20.00%147.22K | -188.33%-337.33K | 685.22%204.23K | 121.18%8.85K | 63.15%-70.97K | 1,555.72%122.69K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,963.89%14.76M | -40.47%121.57K | 15,536.53%4.81M | -289.95%-181.11K | -92.56%27.71K | -226.43%-381.9K | 562.32%204.23K | 73.18%-31.15K | -97.53%95.35K | -81.40%372.69K |
| Net cash flow | ||||||||||
| Beginning cash position | 257.00%6.12M | 284.62%6.09M | -44.14%1.23M | -42.60%2.2M | -60.14%1.31M | -35.03%1.71M | -50.51%1.58M | -42.60%2.2M | -12.33%3.84M | 33.26%3.3M |
| Current changes in cash | 3,562.93%13.24M | -257.10%-186.09K | 994.06%4.83M | 44.10%-897.48K | 91.13%-93.31K | -147.60%-382.24K | 114.11%118.45K | -4.51%-540.37K | -192.90%-1.61M | -183.91%-1.05M |
| Effect of exchange rate changes | -1,008.81%-181.55K | 1,589.77%218.1K | 129.49%23.56K | -157.65%-74.56K | 119.54%8.78K | 88.41%-16.37K | -95.40%12.91K | 35.16%-79.88K | -437.18%-28.94K | -141.80%-44.94K |
| End cash Position | 1,358.12%19.17M | 257.00%6.12M | 284.62%6.09M | -44.14%1.23M | -44.14%1.23M | -60.14%1.31M | -35.03%1.71M | -50.51%1.58M | -42.60%2.2M | -42.60%2.2M |
| Free cash from | 9.48%-1.57M | -186.18%-334.4K | 62.90%-137.48K | 50.25%-1.69M | 103.00%29.76K | -37.36%-1.73M | 150.67%388.02K | -0.36%-370.57K | 18.78%-3.39M | -31.14%-991.56K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.